44 results
8-K
EX-99.1
GRTS
Gritstone Bio Inc
22 Jul 22
Entry into a Material Definitive Agreement
5:11pm
the significant value inherent in our innovative platform and, together with capital conservation measures we’ve implemented, meaningfully extends our cash … to improve patient outcomes and eliminate disease and is yet another example of Hercules’ capabilities to support innovative growth-stage life science
8-K
EX-99.1
GRTS
Gritstone Bio Inc
27 Sep 23
Entry into a Material Definitive Agreement
4:07pm
by the U.S. Department of Health and Human Services to advance a pipeline of new, innovative vaccines and therapeutics providing broader and more durable … NextGen,’ an initiative by the U.S. Department of Health and Human Services (HHS) to advance a pipeline of new, innovative vaccines and therapeutics
8-K
EX-99.1
GRTS
Gritstone Bio Inc
10 Aug 22
Gritstone Appoints Dr. Lawrence “Larry” Corey to its Board of Directors
4:08pm
of Directors and look forward to participating in their efforts to leverage novel antigen discovery and innovative vectors, including self-amplifying mRNA … leverage our innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets. Independently and with our
8-K
EX-99.1
GRTS
Gritstone Bio Inc
25 Oct 22
Entry into a Material Definitive Agreement
4:35pm
, with a single samRNA vaccination
“These data demonstrate exciting preliminary performance of our innovative samRNA vaccine candidates potentially … -stage biotechnology company that aims to create the world’s most potent vaccines. We leverage our innovative vectors and payloads to train multiple arms
8-K
EX-99.1
GRTS
Gritstone Bio Inc
5 Mar 24
Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
4:08pm
randomized dataset from our flagship oncology program, GRANITE, we remain focused on leveraging our innovative technologies to drive transformative advances … company that aims to develop the world’s most potent vaccines. We leverage our innovative vectors and payloads to train multiple arms of the immune
8-K
EX-99.1
e2dqonhpy 20j
1 May 20
Gritstone Oncology Announces the Appointment of Dr. Elaine V. Jones as Chair of the Board of Directors
4:02pm
8-K
EX-99.1
8hgi514p huhxx1hi0rq
17 Dec 21
Gritstone Announces Changes to Its Board of Directors
4:46pm
8-K
EX-99.1
p165 1qoifpchv
17 Aug 21
Gritstone and CEPI Announce Agreement to Advance Second-Generation COVID-19 Vaccine Program (CORAL) Against SARS-CoV-2 Variants of Concern
7:00am
8-K
EX-99.1
ibwnx7hc
4 Jan 22
Other Events
5:21pm
8-K
EX-99.1
hfxfb
8 Nov 23
Gritstone bio Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
4:06pm
8-K
EX-99.1
arp9g1999l4jive4pkq
9 Aug 23
Gritstone bio Reports Second Quarter 2023 Financial Results and Provides Corporate Updates
4:08pm
8-K
EX-99.1
fm9dcsu6wjjskflv4
3 Nov 22
Gritstone Reports Third Quarter 2022 Financial Results and Provides Business Update
4:08pm
8-K
EX-99.1
naiy31w44 ow6
4 Aug 22
Gritstone Reports Second Quarter 2022 Financial Results and Provides Business Update
4:41pm
8-K
EX-99.1
sqyi e3v7lo
9 May 24
Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates
4:07pm
8-K
EX-99.1
kopeu49ahg8fnxm3lb
11 May 23
Gritstone bio Reports First Quarter 2023 Financial Results and Provides Corporate Updates
4:09pm